HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mario García-Domínguez Selected Research

Mario García-Domínguez Research Topics

Disease

3Hyperalgesia
12/2021 - 05/2017
2Neoplasms (Cancer)
11/2022 - 07/2022
1Neuroinflammatory Diseases
11/2023
1Colonic Neoplasms (Colon Cancer)
11/2022
1COVID-19
01/2021
1Hypersensitivity (Allergy)
08/2012

Drug/Important Bio-Agent (IBA)

2Proteins (Proteins, Gene)FDA Link
07/2022 - 01/2021
2D-Ala-peptide T-amideIBA
01/2020 - 05/2017
2Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2020 - 05/2017
1Phosphotransferases (Kinase)IBA
11/2023
1Glucose (Dextrose)FDA LinkGeneric
11/2022
1Oxygen (Dioxygen)IBA
11/2022
1Ligases (Synthetase)IBA
07/2022
1Peptide Hydrolases (Proteases)FDA Link
07/2022
1EnzymesIBA
07/2022
1EndocannabinoidsIBA
12/2021
1Analgesics (Analgesic Drugs)IBA
01/2020
1UCB 35625IBA
05/2017
1Celecoxib (Celebrex)FDA Link
05/2017
12- (1,3- dimethyl- 2,6- dioxo- 1,2,3,6- tetrahydro- 7H- purin- 7- yl)- N- (4- isopropylphenyl)acetamideIBA
05/2017
1Diclofenac (SR 38)FDA LinkGeneric
05/2017
1SC 560IBA
05/2017
1ProstaglandinsIBA
05/2017
1CCR5 Receptors (CCR5 Receptor)IBA
05/2017
1capsazepineIBA
05/2017
1Vitamin K 3 (Menadione)FDA Link
08/2012
1ParaquatIBA
08/2012

Therapy/Procedure

2Analgesia
12/2021 - 01/2020